|
|
|
|
Vol. 57, Issue 5, 1034-1044, May 2000
Departments of Biochemical Pharmacology (B.J.B.F., K.J., P.L., M.J., J.E.L.) and Functional Genomics (W.H.M.L.L.), Janssen Research Foundation, Beerse, Belgium
| |
Abstract |
|---|
|
|
|---|
The ability of the human 5-hydroxytryptamine serotonin type 5A
(h5-ht5A) receptor to couple to G proteins from distinct
families was investigated through the simultaneous infection of
Spodoptera frugiperda 9 insect cells with recombinant
baculoviruses encoding the various proteins. Expression of G proteins
was demonstrated in immunoblots. Receptor-G protein coupling was
monitored by high-affinity agonist binding and agonist-induced
stimulation of
[35S]guanosine-5'-O-(3-thio) triphosphate
binding to membranes. Receptors expressed alone displayed low-affinity
agonist binding, and endogenous G proteins were only poorly stimulated
on the addition of 5-hydroxytryptamine. When receptors were coexpressed
with mammalian Gi/Go proteins (G
i or G
o plus
G
1
2), the coupled phenotype was achieved:
agonists bound with high affinity in a
guanosine-5'-(
,
-imido)triphosphate-sensitive manner and
stimulated
[35S]guanosine-5'-O-(3-thio)triphosphate
binding to high levels. These effects were not observed on coexpression
with Gz/Gs/Gq/11/16 or
G12/13. Various ligands were evaluated for their agonistic, antagonistic, or inverse agonistic behavior in both receptor binding and activation assays. Although Go displayed different
receptor coupling characteristics than Gi proteins, no
clear coupling preference was evident. Coexpression of receptors and
G
i subunits without G
1
2
produced increases in both agonist affinity and maximum G protein
activation that were smaller than those in the presence of
G
1
2, suggesting that
G
1
2 coexpression improves receptor-G protein coupling. Similarly, coexpression of receptors with
G
1
2 alone resulted in an improved
interaction with endogenous G proteins. Our results demonstrate that
h5-ht5A receptors expressed in Spodoptera frugiperda 9 cells selectively and functionally couple to
coexpressed mammalian Gi and Go proteins.
| |
Introduction |
|---|
|
|
|---|
5-Hydroxytryptamine
(5-HT) is a neurotransmitter that affects diverse physiological
processes, including sleep, sexual behavior, food intake, locomotion,
and mood. Schizophrenia, depression, and migraine are among the
pathological conditions that are associated with a dysfunction of 5-HT
transmission. At least 13 different 5-HT receptors have been
identified to date. They belong to the superfamily of
seven-transmembrane-domain receptors that couple to heterotrimeric
guanine nucleotide-binding proteins (G proteins), with the exception of
the 5-ht3 receptor, which forms a 5-HT-gated ion
channel (for review, Saudou and Hen, 1994
; Hoyer and Martin, 1997
).
The 5-ht5A and 5-ht5B
receptors of the 5-ht5 receptor subfamily were
first identified in mice (Plassat et al., 1992
; Matthes et al., 1993
)
and subsequently in rats (Erlander et al., 1993
). Rees et al. (1994)
cloned the human 5-ht5A receptor
(h5-ht5A) homolog, but a
5-ht5B receptor does not seem to be functionally expressed in humans (Rees et al., 1994
). The physiological function of
5-ht5 receptors is still unclear, partly due to a
lack of specific ligands. Recently, results obtained with transgenic
mice lacking the 5-ht5A receptor gene suggested
the involvement of the receptor subtype in exploratory behavior
(Grailhe et al., 1999
). The mouse, rat, and human
5-ht5 receptors have already been expressed in various cell lines. Initially, no effects on signal transduction systems could be demonstrated (Erlander et al., 1993
; Matthes et
al., 1993
), although agonist binding to the recombinant receptor was
found to be guanine nucleotide-sensitive (Plassat et al., 1992
).
Negative coupling to adenylate cyclase activity was first reported for
the rat 5-ht5A receptor expressed in C6 glioma
cells (Carson et al., 1996
). Recently, agonist-induced inhibition of adenylate cyclase activity was also demonstrated for the human 5-ht5A receptor expressed in human embryonic
kidney (HEK) 293 cells (Francken et al., 1998
; Hurley et al., 1998
).
In studies of agonistinduced stimulation of
[35S]guanosine-5'-O-(3-thio)triphosphate
([35S]GTP
S) binding,
h5-ht5A receptors expressed in HEK 293 cells were
shown to couple to pertussis toxin-sensitive G proteins (Francken et
al., 1998
).
The Spodoptera frugiperda 9 (Sf9) insect
cell/baculovirus system has already been successfully used to
reconstitute the interaction of various G protein-coupled receptors
with their cognate G proteins (Butkerait et al., 1995
; Grünewald
et al., 1996
; Barr et al., 1997
). When expressed in Sf9
cells at high levels, heterologous receptors display a predominantly
uncoupled phenotype in the absence of recombinant G proteins due to the
low background of endogenous G proteins (Butkerait et al., 1995
;
Boundy et al., 1996
; Ohtaki et al., 1998
). Therefore, receptor-G
protein coupling specificity can be examined by coexpression in
Sf9 cells of the receptor proteins with a series of G
protein subtypes, through simultaneous infection with the appropriate
recombinant baculoviruses. Successful receptor-G protein interaction is
characterized by high-affinity and guanine nucleotide-sensitive agonist
binding and by receptor-mediated activation of G proteins, as measured
by agonist-stimulated [35S]GTP
S binding or
GTPase activity.
To evaluate the G protein-coupling profile of the
h5-ht5A receptor in detail, we coexpressed
combinations of receptor, G protein
1
2 dimer
(G
1
2), and various G
protein
-subunits (G
subunits) in Sf9 insect cells. We
measured the receptor coupling to members of each of the four families
of G proteins using radioligand binding and
[35S]GTP
S binding to membranes and
investigated the pharmacological properties of various 5-HT receptor
ligands. It was found that the h5-ht5A receptor
selectively couples to G
i/o proteins and that
coexpression of the
G
1
2 dimer facilitates
receptor-G protein coupling.
| |
Experimental Procedures |
|---|
|
|
|---|
Materials.
Sf9 insect cells were obtained from
Invitrogen (Groningen, The Netherlands). The baculovirus transfer
vector pAcGP67A and the BaculoGold DNA were purchased from
PharMingen (San Diego, CA). The transfer vector pBacPAK9 was obtained
from Clontech Laboratories (Palo Alto, CA).
[3H]5-Carboxamidotryptamine (5-CT; 50-100
Ci/mmol), [35S]GTP
S (>1000 Ci/mmol), and
the chemiluminescent Western detection kit (ECL-Plus) were purchased
from Amersham Pharmacia Biotech (Little Chalfont, UK). 5-HT,
5-methoxytryptamine (5-MT), and dihydroergotamine (DHE) were purchased
from Acros Organics (Geel, Belgium). Lysergic acid diethylamide (LSD)
was obtained from Kenija Industriji (Yugoslavia). 5-CT was
obtained from Research Biochemicals Inc. (Natick, MA). Methiothepin was
purchased from Hoffman-La Roche (Basel, Switzerland). Pargyline was
purchased from Sigma-Aldrich (St. Louis, MO). Grace's supplemented
insect cell culture medium, Sf-900 II serum-free insect cell culture
medium, and antibiotic/antimycotic solution were obtained from Life
Technologies (Gaithersburg, MD). Fetal bovine serum was purchased from
BioWhittaker (Walkersville, MD). The protein assay kit and the protein
molecular weight marker were obtained from Bio-Rad Laboratories
(Hercules, CA). Guanosine-5'-(
,
-imido)triphosphate (Gpp(NH)p) and
GDP were obtained from Boehringer-Mannheim (Mannheim, Germany). The
anti-G
i/o/t/z/s rabbit antiserum was purchased from Calbiochem (La Jolla, CA). The rabbit antisera for
G
q/11, G
12, and
G
13 were obtained from Chemicon International
(Temecula, CA). The goat antiserum for G
16 was
purchased from Santa Cruz Biotechnology (Santa Cruz, CA). The
peroxidase-conjugated anti-rabbit and anti-goat secondary antibodies
were obtained from Jackson ImmunoResearch Laboratories (West Grove, PE).
i1, G
i2,
G
i3, and G
o subunits
were gifts from Dr. J. Garrison (University of Virginia) (Graber et
al., 1992
z was a
gift from Dr. D. Manning (University of Pennsylvania) (Butkerait et
al., 1995
s-short-B, mouse G
q,
mouse G
11, and human
G
16 were gifts from Dr. A. Gilman and Dr. T. Kozasa (University of Texas) (Hepler et al., 1993
12 and G
13 were
gifts from Dr. D. Dhanasekaran (Temple University, PA). The bovine
G
1
2 transfer vector
was a gift from Dr. T. Haga (University of Tokyo, Japan) (Nakamura et
al., 1995Cloning of h5-ht5A Receptor cDNA.
The coding
region of the human 5-ht5A receptor was amplified
from a QuickScreen cDNA library (Clontech) by polymerase chain reaction
using primers 5'-GCGATATGGACCCAGAGATGGATTTACCAGTGAACC-3' and
5'-GCCTCGAGCCTCAGTGTTGCCTAGAAAAGAAGTTCTTG-3'. The inclusion of
restriction sites (EcoRV and XhoI) within the
oligonucleotide primers allowed cloning of the polymerase chain
reaction fragment into the pcDNA3 vector (Invitrogen). The sequence of
the insert was identical to that reported by Hurley et al. (1998)
and
contained a single silent mutation (T to C at nucleotide 300, counting
from the A of the start codon), compared with the sequence deposited in
the GenBank/EMBL database (accession numbers X81411 and X81412) by Rees
et al. (1994)
.
Construction of Recombinant Transfer Vector. The h5-ht5A cDNA clone in pcDNA3 was digested with PstI, blunt-ended with Klenow DNA polymerase, and digested with XbaI, yielding a 1145-bp fragment encoding the h5-ht5A receptor. This fragment was subcloned into the BamHI (filled in with Klenow DNA polymerase) and XbaI positions of the multiple cloning site of the baculovirus transfer vector pAcGP67A, such that the gp67 signal sequence was fused in frame to the N terminus of the h5-ht5A coding sequence via a nine-amino acid linker sequence (gp67-ADRCDMDPE-h5-ht5A). For the pBacPAK9-based transfer vector, the h5-ht5A cDNA was excised from the pcDNA3 clone by digestion with EcoRI and XhoI. The 1142-bp fragment encoding the h5-ht5A receptor was subcloned into the multiple cloning site of the transfer vector pBacPAK9 that was digested with the same restriction enzymes. Protein expression was under control of the polyhedrin promoter in both transfer vectors. The DNA insert sequences were confirmed by sequencing both strands of the double-stranded DNA.
Generation of Recombinant Baculoviruses.
Transfer of the
h5-ht5A receptor cDNA into the wild-type
Autographa californica nuclear polyhedrosis virus genome was
accomplished by homologous recombination. Sf9 insect cells
were cotransfected with linearized modified A. californica
nuclear polyhedrosis virus baculovirus DNA (BaculoGold) and the
h5-ht5A-containing recombinant transfer vector
using standard techniques (O'Reilly et al., 1992
). Purification of
recombinant viruses, amplification of purified virus stocks, and
determination of virus titers were performed as described by O'Reilly
et al. (1992)
.
Insect Cell Culture and Baculovirus Infection.
Sf9 cells were grown at 27°C and at an ambient atmosphere
in suspension culture using spinner flasks or in monolayers. For viral
stock production, Grace's insect cell culture medium was used
supplemented with 10% fetal bovine serum, 0.2 mM
L-glutamine, and 1% antibiotic/antimycotic
solution, whereas Sf-900 II serum-free insect cell culture medium,
supplemented with 0.2 mM L-glutamine and 1%
antibiotic/antimycotic solution, was used in recombinant protein
expression experiments. Cell viability was determined by trypan blue
staining. Cells (50-500 ml) at a density of 1 × 106 cells/ml (log phase growth) were infected
with a h5-ht5A receptor-encoding baculovirus at a
multiplicity of infection (m.o.i.) of 2 (unless stated otherwise), with
a G
1
2-encoding virus
(m.o.i. = 1) and/or with a G
-encoding virus (m.o.i. = 2-4). For the
expression of single G
subunits, the m.o.i. was 4 for any G
baculovirus, whereas for the expression of multiple G
subunits
(G
i1, G
i2,
G
i3, and G
o,
abbreviated as G
i/o) the m.o.i. was 2 for each
virus. At 48 h postinfection, cells were harvested by
centrifugation (10 min at 2000g at 4°C), washed with
ice-cold PBS, and stored at
80°C or used directly for membrane preparation.
Membrane Preparation and Determination of Protein Content.
Harvested Sf9 cells were washed with ice-cold 50 mM Tris-HCl
buffer, pH 7.4; resuspended in hypotonic 10 mM Tris-HCl buffer, pH 7.4;
and homogenized with an UltraTurrax homogenizer (Janke and Kunkel,
Staufen, Germany) for 5 s. The homogenate was centrifuged at
30,000g for 20 min at 4°C. The membrane pellet was
resuspended in 50 mM Tris-HCl buffer, pH 7.4, containing 10% glycerol
and stored in aliquots at
80°C. Protein content in membrane
preparations was estimated with the Bradford protein assay (Bradford,
1976
), using the Bio-Rad kit. BSA was used as a standard.
Immunoblot Analysis.
Membrane protein (1, 4, or 10 µg) was
incubated in 62.5 mM Tris-HCl buffer, pH 6.8, containing 10% glycerol,
5% SDS, and 0.01% bromophenol blue at 37°C for 2 h. Proteins
were separated by SDS-polyacrylamide gel electrophoresis and were
transferred to polyvinylidene-difluoride membranes, using standard
techniques. Immunodetection of G
subunits was performed with 1:1000
dilutions of the G
i/o/t/z/s,
G
q/11, G
16,
G
12, and G
13
antisera. The peroxidase-conjugated anti-rabbit and anti-goat secondary
antibodies were diluted 1:5000. Bands were visualized by
chemiluminescence using the ECL-Plus detection kit.
Radioligand Binding.
[3H]5-CT
binding experiments were performed essentially as described previously
(Francken et al., 1998
). Briefly, 6 µg of membrane protein was
diluted in 50 mM Tris-HCl buffer, pH 7.4, containing 10 mM
MgCl2, 1 mM EGTA, and 10 µM pargyline and
incubated with [3H]5-CT for 1 h at 25°C
in a volume of 0.5 ml. Nonspecific binding was estimated in the
presence of 10 µM methiothepin. Reactions were terminated by rapid
filtration through glass fiber (GF/B) filters (Whatman, Kent, UK)
presoaked in 0.1% polyethyleneimine using a Brandel (Gaithersburg, MD)
96-sample harvester. Filters were washed twice, and filter-bound
radioactivity was counted in a liquid scintillation spectrometer
(Tricarb) using scintillation fluid (Ultima Gold MV; Packard Instrument
Company, Meriden, CT). For radioligand concentration-binding isotherms,
12 concentrations of [3H]5-CT, in a range of
0.1 to 25 nM, were used. Competition binding experiments were performed
using 2 nM [3H]5-CT; compounds were added at 7 to 12 concentrations.
[35S]GTP
S Binding.
[35S]GTP
S binding experiments were performed
as previously described (Francken et al., 1998
). Briefly, 12 µg of
membrane protein was diluted in 50 mM Tris-HCl buffer, pH 7.4, containing 50 mM NaCl, 10 mM MgCl2, 1 mM EGTA,
0.1 mM dithiothreitol, 10 µM pargyline, and 1 µM GDP and
preincubated with compound for 30 min at 30°C in a volume of 0.45 ml.
Then, 50 µl of [35S]GTP
S in assay buffer
was added to a final concentration of 0.2 nM, and the assay mixtures
were further incubated for 30 min at 30°C. Reactions were terminated
by rapid filtration through GF/B filters, presoaked in assay buffer,
using a 40-well manual filtration manifold or a Brandel 48-sample
harvester. Filters were washed twice, and filter-bound radioactivity
was counted in a liquid scintillation spectrometer. Basal
[35S]GTP
S binding was measured in the
absence of compound. Compounds were added at 9 to 11 concentrations.
Nonspecific [35S]GTP
S binding, as measured
in the presence of 100 µM GTP
S, did not exceed 10% of basal
binding and was never subtracted from experimental data.
Data Analysis.
Radioligand concentration-binding isotherms
(rectangular hyperbola) were calculated by nonlinear regression
analysis according to algorithms described by Oestreicher and Pinto
(1987)
, and sigmoidal inhibition curves were calculated by nonlinear
regression using the Prism program (GraphPad Software, San Diego, CA).
Bmax and Kd
values of the radioligand and IC50 values of
inhibitors were derived from the curve fitting.
S binding was
calculated as 100 times the difference between stimulated and basal
binding (in cpm) divided by the amount of basal binding (in cpm).
Agonist concentration-response curves and antagonist inhibition curves
were analyzed by nonlinear regression using GraphPad Prism.
EC50 and IC50 values were
derived from the curves. IC50 values were
corrected as follows: corrected IC50
(IC50-corr) = IC50/{1 + [5-HT]/EC50(5-HT)}. Relative maximum stimulation (Emax) values were calculated
as percentage of the maximum stimulation obtained with 10 µM 5-HT,
and relative maximum inhibition (Imax)
values were calculated as percentage of the inhibition from maximum
5-HT (10 µM)-stimulated [35S]GTP
S binding
to basal level.
Statistical F tests and Student's t tests were
performed, and all figures were prepared using GraphPad Prism.
| |
Results |
|---|
|
|
|---|
Expression of h5-ht5A Receptors and G Protein Subunits in Sf9 Insect Cells. The h5-ht5A receptor coding sequence was cloned from a cDNA library, and recombinant baculoviruses were generated and used to infect Sf9 cells. In preliminary [3H]5-CT concentration-binding experiments on membranes of Sf9 cells infected at an m.o.i. of 3, higher expression levels were found for virus generated with the pAcGP67A transfer vector (Bmax = 63 ± 11 pmol/mg protein, Kd = 10.1 ± 2.0 nM, mean ± S.D., n = 5) than for pBacPAK9-based virus (Bmax = 23 ± 2 pmol/mg protein, Kd = 5.6 ± 1.0 nM, n = 3), probably due to the presence of the gp67 signal sequence. No specific [3H]5-CT binding could be detected to membranes of uninfected or wild-type baculovirus-infected cells (data not shown). Further expression experiments were performed with the pAcGP67A-based virus at an m.o.i. of 2.
The effect of coexpression of various G protein subunits (m.o.i. = 1-4) on the affinity of [3H]5-CT for the h5-ht5A receptor was determined using [3H]5-CT concentration-binding experiments. Examples of [3H]5-CT saturation curves are presented in Fig. 1. Table 1 summarizes the mean Kd and Bmax values and shows the binding data for h5-ht5A-HEK 293 cell membranes for comparison (Francken et al., 1998
1 and G
2
(G
1
2 baculovirus, m.o.i. = 1) resulted in a slight, but statistically significant, increase in [3H]5-CT affinity (Student's
t test, P < .05) (Fig. 1A, Table 1), suggesting improved coupling of the recombinant receptors to endogenous G proteins. Coexpression of h5-ht5A receptors
with G
i1, G
i2, or
G
i3 (m.o.i. = 4) or with a mixture of
G
i1, G
i2,
G
i3, and G
o (further
designated as G
i/o; m.o.i. = 2 for each virus)
also significantly increased [3H]5-CT affinity
(Student's t test, P < .05) (Fig. 1B),
whereas no effect was observed with G
o,
G
z, G
s,
G
11, G
16,
G
12, or G
13 subunits
(Table 1). The small, but statistically significant, increase in
[3H]5-CT affinity that was observed on
coexpression with G
q is considered as a
spurious finding, considering the lack of a Gpp(NH)p effect on agonist
binding (Table 1, see Fig. 4). When
G
1
2 subunits (m.o.i. = 1) were expressed in addition to G
subunits and receptors, [3H]5-CT affinities further increased for
G
i/o, G
i1,
G
i2, G
i3, and
G
o (Student's t test,
P < .05) (Fig. 1B) but not for
G
z, G
s,
G
q, G
11,
G
16, G
12, or
G
13 (Table 1).
|
|
subunits was verified by immunoblot
analysis using commercially available antibodies. Figure 2 shows immunoblots for the membranes of
Sf9 cells expressing receptor and mammalian G protein
trimers. For the different G
proteins, immunoreactivity was
demonstrated in the respective experimental membranes. It should be
noted that using the same antiserum directed against a common peptide
sequence, the immunoreactivity for G
o was much
stronger than that for the G
i subunits,
suggesting higher G
protein expression levels.
|
protein-encoding baculoviruses
implicates an increased overall number of G proteins (Fig. 2).
Alternatively, coexpression with the mixture of
Gi/o proteins might mimic a more natural
situation, in which the receptor is able to interact with all of the
used G protein subtypes. It should be noted that a decrease in receptor number was not systematically observed on coexpression with G protein
subunits. For example, coexpression with G
q
and G
1
2 resulted in a
Bmax value that was higher than when the
receptor was expressed alone (Table 1). Differences in receptor
expression levels between similar experiments were also observed by
other groups (Butkerait et al., 1995Pharmacological Characterization of h5-ht5A Receptors
Expressed Alone or Coexpressed with G Protein Subunits.
Various
5-HT receptor ligands were used to inhibit
[3H]5-CT binding to membranes of
baculovirus-infected Sf9 insect cells. pIC50 values were derived from inhibition curves
and are summarized in Table 2. The
pharmacological profile of h5-ht5A receptors expressed alone in Sf9 cells was different from that in
stably transfected h5-ht5A-HEK 293 cells; the
agonists 5-CT, 5-HT, and 5-MT had 3.2- to 3.6-fold lower affinities
(Student's t test, P < .05), whereas DHE,
LSD, and methiothepin had slightly higher affinities for the receptor
expressed alone in Sf9 cells. The rank order of potency of
the tested compounds was LSD > methiothepin > 5-CT > DHE > 5-HT > 5-MT. This profile did not change on
coexpression with G
1
2
subunits, although agonist affinities were slightly, but never
significantly, increased.
|
1
2 together with
G
i1, G
i2,
G
i3, G
o, or the
mixture of G
i/o subunits, but not together
with Gz or Gs, resulted in
an increase in the agonist affinities; the pIC50
values were very similar to those for h5-ht5A-HEK 293 membranes (Student's t test, P > .05)
(Table 2). Figure 3 compares the
inhibition curves of the tested compounds for Sf9 cells
expressing the h5-ht5A receptor alone and in
combination with G
i1 and
G
1
2. In contrast to
the agonists, the affinity of methiothepin significantly decreased up
to 1 log unit on coexpression of
Gi/Go proteins. Decreases
in DHE and LSD affinities were minor on coexpression of individual
Gi or Go proteins but
appeared significant on coexpression of the mixture of
Gi/o proteins.
|
Effect of Gpp(NH)p on [3H]5-CT Binding.
The interaction of h5-ht5A receptors with
endogenous or coexpressed G proteins in membranes of
baculovirus-infected Sf9 cells was investigated by measuring
the sensitivity of agonist binding to the addition of the
nonhydrolyzable GTP analog Gpp(NH)p.
[3H]5-CT concentration-binding experiments in
the presence and absence of 100 µM Gpp(NH)p were performed in
parallel, and the Kd values were compared
using a paired Student's t test (Table 1). Figure 4 visualizes the ratio of
Kd values for
[3H]5-CT binding in the presence and absence of
Gpp(NH)p. The affinity of [3H]5-CT observed for
the h5-ht5A receptor expressed alone was
unaffected by Gpp(NH)p, suggesting the absence of interaction with
endogenous G proteins. The small increase in affinity achieved by
G
1
2 coexpression was
completely reversed by Gpp(NH)p. The affinity of
[3H]5-CT significantly decreased on Gpp(NH)p
addition to membranes of Sf9 cells coexpressing the
h5-HT5A receptor together with
G
1
2 and either the
G
i/o mixture, G
i1,
G
i2, G
i3, or
G
o, whereas no significant decrease in
affinity was observed for the other G protein coexpressions (Fig. 4).
|
5-HT-Stimulated [35S]GTP
S Binding.
Receptor-mediated activation of G proteins was examined by
concentration-dependent 5-HT-stimulated binding of
[35S]GTP
S to membranes of
baculovirus-infected Sf9 cells. The activation of G proteins
involves stimulation of GDP/GTP exchange at the G
subunit and can be
measured by the incorporation of the nonhydrolyzable GTP analog
[35S]GTP
S (Wieland and Jakobs, 1994
).
Figure 5 depicts the dose-dependent increase in 5-HT-stimulated [35S]GTP
S
binding for Sf9 cells expressing
h5-ht5A receptors alone or together with
G
1
2 and/or the
G
i/o mixture. In membranes of Sf9
cells expressing only h5-ht5A receptors without
mammalian G protein subunits, stimulation of the receptors with 5-HT
resulted in an increase in [35S]GTP
S binding
to a maximum of 40% over basal, probably due to the activation of
endogenous G proteins. Coexpression of
G
1
2 resulted in a
significant increase of the maximum response (Student's t
test, P < .05), up to 110% over basal. When the
receptor was coexpressed with the mixture of
G
i/o subunits, without or with G
1
2, the maximum
stimulation was 330 and 570%, respectively. The effect of 5-HT was
specific for the h5-ht5A receptor, because 5-HT
did not affect [35S]GTP
S binding to
membranes from uninfected or wild-type baculovirus-infected Sf9 cells (data not shown).
|
i1, G
i2,
G
i3, or G
o subunits
yielded maximum responses that were comparable with those for the
G
i/o mixture. For the G
i subunits, additional coexpression of
G
1
2 markedly
increased stimulation of [35S]GTP
S binding,
as observed for the G
i/o mixture (Table 3). For G
o, however, coexpression with
G
1
2 significantly
(Student's t test, P < .05) decreased the
maximum stimulation of [35S]GTP
S binding. It
should be noted that the absolute values for basal
[35S]GTP
S binding (in cpm) were 2.6-fold
higher for
G
o/G
1
2
than for
G
i/G
1
2
when coexpressed with h5-ht5A receptors, in
contrast to coexpressions with G
i or
G
o, which showed comparable levels of
agonist-independent [35S]GTP
S binding (data
not shown). For the coexpressions including G
z, G
s,
G
q, G
11, and
G
16, a small 5-HT-induced stimulation of
[35S]GTP
S binding was detected, but the
maximum stimulation was never significantly higher than the appropriate
control sample. No stimulation was observed for the
G
12 and G
13
coexpressions.
|
Modulation of [35S]GTP
S Binding by 5-HT Receptor
Ligands.
Several 5-HT receptor ligands were examined for their
ability to modulate [35S]GTP
S binding to
membranes of Sf9 cells, expressing
h5-ht5A receptors with
G
1
2 and either
G
i1, G
i2,
G
i3, or G
o. Figure 6 shows, as an example, the mean curves
for the coexpression of h5-ht5A receptors with
G
i1 and
G
1
2. Table
4 summarizes the pEC50, Emax,
pIC50-corr, and Imax
values from all [35S]GTP
S dose-response and
inhibition curves.
|
|
S binding to about 50% of the 5-HT
level for the Gi coexpressions (i.e., behaved as
partial agonists), whereas for the Go
coexpression, maximum stimulation approached the level of 5-HT (i.e.,
DHE and LSD behaved as full agonists). Methiothepin behaved as an
inverse agonist as it inhibited [35S]GTP
S
binding to about
10% below its basal level (5-HT level set at 100%)
for G
i1, G
i2, or
G
i3 and to
24% below its basal level for
G
o (see Fig. 6 for
G
i1; data not shown for
G
i2, G
i3, and
G
o). However, no reproducible curves could be
derived from the methiothepin data points. The antagonistic properties
of DHE, LSD, and methiothepin were investigated using
[35S]GTP
S binding to membranes of the same
four coexpressions. DHE and LSD inhibited 5-HT (10 µM)-stimulated
[35S]GTP
S binding to the level of their own
agonistic effect. Methiothepin behaved again as an inverse agonist,
inhibiting [35S]GTP
S binding below the basal level.
| |
Discussion |
|---|
|
|
|---|
Little is known about the pharmacological and functional
properties of cloned 5-ht5 receptors. Recently,
h5-ht5A receptors were shown to mediate
inhibition of adenylate cyclase activity in transfected HEK 293 cells
(Francken et al., 1998
; Hurley et al., 1998
). High-affinity agonist
binding and agonist-stimulated [35S]GTP
S
binding to h5-ht5A-HEK 293 membranes were found
to be pertussis toxin-sensitive (Francken et al., 1998
), indicating the
involvement of Gi/Go
proteins. To provide further insight in its signaling properties, we
coexpressed the h5-ht5A receptor in
Sf9 insect cells with a series of 11 mammalian G proteins, from each of the four G
families. Using radioligand and
[35S]GTP
S binding assays, we demonstrated
selective coupling of the h5-ht5A receptor to
coexpressed Gi and Go
proteins and the absence of coupling to
Gz/Gs/Gq/G11/G16/G12
and G13 proteins. Hence, the
h5-HT5A receptor does not show promiscuous
coupling to various G protein families. Although no clear coupling
preference to either of the
Gi/Go subtypes was evident,
we have observed differences in the coupling behavior of
Go versus Gi.
The overexpression in Sf9 cells of
h5-ht5A receptors alone resulted in a
predominantly uncoupled phenotype, as demonstrated by guanine
nucleotide-insensitive, low-affinity agonist binding. Although not
evident from the binding data, h5-ht5A receptors coupled to endogenous G proteins to some extent; 5-HT stimulated [35S]GTP
S binding to 40% over basal. We
conclude that a large excess of uncoupled receptors is present in
h5-ht5A-Sf9 membranes. Although the
activation of G proteins by a small fraction of coupled receptors can
be detected due to the sensitivity of the
[35S]GTP
S binding assay, the curve-fitting
algorithms for the concentration-binding isotherms cannot reliably
detect a high-affinity binding component of less than 10% of the
Bmax value.
When the h5-ht5A receptor was coexpressed with
Gi1/Gi2/Gi3
or Go proteins
(G
1
2
heterotrimers), the coupled phenotype was achieved, as evident from
guanine nucleotide-sensitive, high-affinity agonist binding. In
addition, the affinity of methiothepin, which was identified as an
inverse agonist at h5-ht5A-HEK 293 cells (Francken et al., 1998
), decreased on coexpression of
Gi/Go proteins. These
observations are consistent with two distinct states of the
h5-ht5A receptor, according to the two-state
model (Leff, 1995
). Receptors are proposed to exist in an active form
(R*) that is G protein-coupled and an inactive form (R). Agonists show high affinity for R* and low affinity for R, whereas inverse agonists display the opposite behavior (Milligan et al., 1995
). Our binding data
suggest that h5-ht5A receptors expressed in
Sf9 cells convert to the active, high agonist affinity state
(R*) through interaction with coexpressed
Gi/Go proteins. Remarkably,
the affinities of DHE and LSD, which were identified as partial
agonists at h5-ht5A-HEK 293 cells, decreased on
coexpression of Gi and/or
Go proteins. This observation might indicate that
the two-state model of agonist action is not generally applicable to
partial agonists.
Evidence for h5-ht5A receptor-mediated
Gi/Go protein activation
was obtained using [35S]GTP
S assays. The
maximum level of 5-HT-stimulated [35S]GTP
S
binding to coexpressed Go proteins was similar to
that found for h5-ht5A-HEK 293 cells, whereas
Gi1/Gi2/Gi3
and the mixture of Gi/o proteins were stimulated
by 5-HT with approximately 4-fold higher efficacy. The lower level of
5-HT-mediated stimulation of Go, compared with
Gi, might be explained by the 2.6-fold higher basal [35S]GTP
S binding that was found for
coexpressed Go. This high agonist-independent [35S]GTP
S binding most probably originates
from a larger number of Go proteins in the
Sf9 membranes compared with Gi, as
G
o appeared more abundant than the various
G
i subunits in immunoblot analysis. Alternatively, the h5-ht5A receptor may exhibit
stronger constitutive activation of Go, compared
with Gi. High agonist-independent binding complicates the detection of agonist-induced increases in
[35S]GTP
S binding (Wieland and Jakobs,
1994
). It could be that the assay conditions (e.g., buffer composition
and incubation temperature) optimal for Go
activation differ from the applied conditions, such that the actual
maximum stimulation of Go by 5-HT might well be
higher than reported.
Coexpression of the h5-ht5A receptor with one of
the other G proteins tested
(Gz/Gs/Gq/G11/G16/G12
or G13) had no effect on agonist binding, and no
or only minor 5-HT-induced activation of these G proteins could be
detected. The expression of the different heterologous G
proteins in
the Sf9 membranes was confirmed using immunoblotting. All
G
proteins were highly expressed, and only G
12 showed weak immunoreactivity. Hence, poor
subunit expression is not the reason for the absence of effects for the
various G proteins, except perhaps for G
12. It
should be noted that in the [35S]GTP
S
studies, the assay conditions were not optimized for each individual G
protein type. Under the applied conditions, which were optimized for
[35S]GTP
S binding to
h5-ht5A-HEK 293 membranes, activation of some G
protein types may therefore be suboptimal. As the need to optimize assay conditions for individual G proteins has been reported previously (Wieland and Jacobs, 1994
), it would be rash to conclude the absolute absence of h5-ht5A receptor coupling to
Gz/Gs/Gq/G11/G16/G12
or G13 proteins based exclusively on the absence
of increases in [35S]GTP
S binding. The lack
of receptor interaction with these G proteins is only suggested by the
fact that coexpression of these G proteins did not induce guanine
nucleotide-sensitive, high-affinity agonist binding to the
h5-ht5A receptor. It appears that
h5-ht5A receptors selectively couple to
Gi/Go proteins, which is in
agreement with the finding that pertussis toxin pretreatment completely abolished high-affinity agonist binding and 5-HT-stimulated
[35S]GTP
S binding to
h5-ht5A-HEK 293 membranes (Francken et al., 1998
).
The G
complex has already been shown to be required for optimal
receptor-G protein interaction (Fung, 1983
; Butkerait et al., 1995
). We
have used the G
1
2
dimer to enhance G protein coupling to the
h5-ht5A receptor, because this dimer was reported to interact with members of the four G
families (Barr et al., 1997
).
However, the subunit composition of G
affects receptor-G protein
coupling specificity (Kisselev and Gautam, 1993
; Kleuss et al., 1993
;
Richardson and Robishaw, 1999
), such that other G
subunit
compositions may yield different receptor coupling profiles. Therefore,
we also investigated h5-ht5A receptor-G protein coupling in the absence of the mammalian
G
1
2 complex. The
interaction of receptor with G
i1,
G
i2, and G
i3 could
still be detected in agonist binding and
[35S]GTP
S assays, but it was indeed less
effective than that in the presence of
G
1
2. Remarkably,
coexpression with G
o did not induce
high-affinity agonist binding in the absence of
G
1
2. Previously,
Jockers et al. (1994)
found similar results for adenosine A1 receptors expressed in Escherichia
coli; reconstitution of high-affinity agonist binding by purified
G proteins was poor in the absence of G
for
Go, but not for Gi, whereas
in the presence of G
, their maximum responses were similar.
Despite the lack of effect on agonist affinity of
G
o, the activation of
h5-ht5A receptors produced a maximum stimulation
of [35S]GTP
S binding similar to
G
i subunits. Coexpression of
h5-ht5A receptors and either
G
z/G
s/G
q/G
11/G
16/G
12
or G
13 without G
1
2 did not result in
the coupled phenotype, as expected from the lack of effect when
G
1
2 heterotrimers
were expressed. We conclude that the
G
1
2 complex greatly
facilitates coupling of Gi/o proteins to the
h5-ht5A receptor when coexpressed in
Sf9 cells.
Coexpression of h5-ht5A receptors and
G
1
2 without mammalian
G
subunits revealed that
G
1
2 enhances
interaction of heterologous receptor with insect G proteins. Similar
results were reported for the serotonin 5-HT1A
and the dopamine D2S receptor (Butkerait et al.,
1995
; Boundy et al., 1996
). Considering this finding, one should note
that an improved interaction of recombinant receptors with endogenous G
proteins due to coexpressed
G
1
2 subunits may confuse the interpretation of receptor-G protein interaction
specificity. Regardless, it is clear that the overexpression of
specifically interacting G proteins should yield effects that exceed
these observed for the appropriate controls.
For some receptors that couple to pertussis toxin-sensitive G proteins,
preferential interaction with one of the
Gi/Go subtypes has been
demonstrated (Senogles et al., 1990
; Parker et al., 1991
; Rubinstein et
al., 1991
; Grünewald et al., 1996
; Clawges et al., 1997
; Lorenzen
et al., 1998
). Our data indicate that the heterotrimeric Gi1, Gi2,
Gi3, or Go proteins
interacted equally well with the h5-ht5A receptor
to induce its high-affinity conformation, and no significant
differences in the affinities of the tested compounds were observed.
However, in contrast to G
i,
G
o did not induce high-affinity agonist
binding in the absence of
G
1
2, suggesting diminished receptor interaction. Furthermore, some striking differences between Go and Gi proteins
appeared from the [35S]GTP
S experiments.
Maximum stimulation of [35S]GTP
S binding by
5-HT was significantly lower at Go than at Gi, possibly due to the high agonist-independent
[35S]GTP
S binding to
Go. In addition, the relative efficacies of DHE
and LSD were dependent on the G protein type expressed. Both compounds
were full agonists at the h5-ht5A receptor when
coexpressed with Go, whereas coexpression with
Gi proteins resulted in partial agonistic
behavior, which was also found at the h5-HT5A-HEK
293 membranes (Francken et al., 1998
). These data might be explained by
a difference in receptor/G protein stoichiometry, which can influence
both agonist potency and efficacy (Hermans et al., 1999
). Alternatively, the efficacy of compounds may be determined by the type
of G protein interacting with the receptor. In this respect, Yang and
Lanier (1999)
have reported that recombinant expression of
G
o, but not G
i1,
increased the relative efficacy of clonidine in NIH-3T3 cells
cotransfected with
2-adrenergic receptor and G
subunit, an effect that was not an issue of G protein or receptor levels. Although we cannot exclude that differences in
h5-ht5A receptor-to-G protein ratio cause the
distinct behavior of Go and
Gi proteins, it is tempting to speculate that
structural differences exist in their interaction with the
h5-HT5A receptor. However, differences in the
nucleotide binding properties of the G protein types themselves should
also be taken into account; as such, Go may be
easier to activate by receptors than Gi.
In summary, the h5-HT5A receptor selectively coupled to mammalian Gi1/Gi2/Gi3 and Go but not to Gz/Gs/Gq/11/16 or G12/13 proteins, when coexpressed in Sf9 insect cells. Although Go displayed different receptor coupling characteristics than Gi proteins, no clear coupling preference was evident.
| |
Acknowledgments |
|---|
We thank Dr. Menelas Pangalos and Liesbet van der Helm for cloning of the h5-ht5A receptor cDNA and Isolde Peters and Hubert Hamelink for their practical assistance in the binding studies. We also thank Jurgen Vanhauwe and Dr. Reginald Brys for helpful discussion and suggestions. We are grateful to Drs. J. Garrison, D. Manning, A. Gilman, T. Kozasa, D. Dhanasekaran, and T. Haga for kindly providing G protein subunit recombinant transfer vectors or baculoviruses.
| |
Footnotes |
|---|
Received July 12, 1999; Accepted January 6, 2000
This work was supported by a grant from the IWT (Vlaams Instituut voor de Bevordering van het Wetenschappelijk-Technologisch Onderzoek in de Industrie).
Send reprint requests to: Dr. Josée E. Leysen, Janssen Pharmaceutica, Turnhoutseweg 30, B-2340 Beerse, Belgium. E-mail: jleysen2{at}janbe.jnj.com
| |
Abbreviations |
|---|
5-HT, 5-hydroxytryptamine (serotonin);
GTP
S, guanosine-5'-O-(3-thio)triphosphate;
5-CT, 5-carboxamidotryptamine;
5-MT, 5-methoxytryptamine;
DHE, dihydroergotamine;
Emax, relative maximum
stimulation;
G protein, guanine nucleotide-binding protein;
Gi/o, combination of Gi1, Gi2,
Gi3, and Go proteins;
Gpp(NH)p, guanosine-5'-(
,
-imido)triphosphate;
G
, G protein
-subunit;
G
1
2, G protein
1
2 dimer;
h5-ht5A, human
5-hydroxytryptamine type 5A;
HEK, human embryonic kidney;
IC50-corr, corrected IC50;
Imax, relative maximum inhibition;
LSD, lysergic acid diethylamide;
m.o.i., multiplicity of infection;
Sf9, Spodoptera frugiperda 9.
| |
References |
|---|
|
|
|---|
and G11
: Activation of purified phospholipase C isozymes by G
subunits.
J Biol Chem
268:
14367-14375
receptors on the pharmacological properties of agonists and antagonists.
Br J Pharmacol
126:
873-882[Medline].
subunit type in a G protein.
J Biol Chem
268:
24519-24522
subunits of heterotrimeric G proteins.
Science (Wash DC)
259:
832-834
from Sf9 cells: Activation of purified phospholipase C isozymes by G-protein
subunits.
Proc Natl Acad Sci USA
90:
9176-9180
Subunits are palmitoylated.
Proc Natl Acad Sci USA
90:
3675-3679
subunits by partial agonists of the adenosine A1 receptor.
Biochem Pharmacol
56:
1287-1293[Medline].
(G14
), GL2
(G11
), and Gq
expressed in the baculovirus-insect cell system.
J Biol Chem
270:
6246-6253
2A-adrenergic receptor discriminates between Gi heterotrimers of different 
subunit composition in Sf9 insect cell membranes.
J Biol Chem
274:
13525-13533
-adrenergic receptor among Gs, Gi's, and Go: Assay using recombinant
subunits in reconstituted phospholipids.
Biochemistry
30:
10769-10777[Medline].
-thio)triphosphate binding by G proteins.
Methods Enzymol
237:
3-13[Medline].This article has been cited by other articles:
![]() |
W. R. Leifert, A. L. Aloia, O. Bucco, R. V. Glatz, and E. J. McMurchie G-Protein-Coupled Receptors in Drug Discovery: Nanosizing Using Cell-Free Technologies and Molecular Biology Approaches J Biomol Screen, December 1, 2005; 10(8): 765 - 779. [Abstract] [PDF] |
||||
![]() |
K. Masuda, H. Itoh, T. Sakihama, C. Akiyama, K. Takahashi, R. Fukuda, T. Yokomizo, T. Shimizu, T. Kodama, and T. Hamakubo A Combinatorial G Protein-coupled Receptor Reconstitution System on Budded Baculovirus: EVIDENCE FOR G{alpha}i AND G{alpha}o COUPLING TO A HUMAN LEUKOTRIENE B4 RECEPTOR J. Biol. Chem., June 27, 2003; 278(27): 24552 - 24562. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Azzi, G. Pineyro, S. Pontier, S. Parent, H. Ansanay, and M. Bouvier Allosteric Effects of G Protein Overexpression on the Binding of beta -Adrenergic Ligands with Distinct Inverse Efficacies Mol. Pharmacol., November 1, 2001; 60(5): 999 - 1007. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||